For many years, several studies investigated the role of CD26 on CSCs, reporting its involvement in gastrointestinal carcinoma, lung cancer, melanoma, and mesothelioma, resulting in its responsibility for malignant cell transformation [9,10,11]. This evidence concerns the gene DPP4 and melanoma.